Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

DowDuPont Inc. Form S-4 registration statement declared effective by SECqrcode

Jun. 13, 2016

Favorites Print
Jun. 13, 2016
DuPont and Dow Chemical announced that the registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission ("SEC") by DowDuPont Inc. on March 1, 2016, as amended, was declared effective on June 9, 2016. The registration statement was filed in connection with the proposed merger of equals of Dow and DuPont and includes a joint proxy statement of Dow and DuPont and a prospectus of DowDuPont.
The companies also announced that they have each scheduled special meetings of their respective stockholders to seek adoption of the merger agreement and approval of related matters from such stockholders, a key milestone in the process to merge and pursue the intended spins of three highly focused, independent companies.
DuPont's special meeting of stockholders will be held on July 20, 2016 at 10:00am, at 974 Centre Road, Chestnut Run Plaza Building 730, Wilmington, DE 19805.
Dow's special meeting of stockholders will be held on July 20, 2016 at 10:00am, at the Employee Development Center, Dow Corporate Center, Midland, Michigan 48674.
Each company's common stockholders of record as of the close of business on June 2, 2016 are entitled to vote at the respective meeting and will receive the joint proxy statement/prospectus, which will be mailed to shareholders beginning June 10, 2016. The joint proxy statement/prospectus contains important information about the proposed merger transactions, the merger agreement and the proposals to be considered at the special meetings. 
Both Dow's and DuPont's boards of directors unanimously recommend that its respective stockholders vote "FOR" adoption of the merger agreement and approval of related matters. The parties continue to expect the transaction to close in the second half of 2016, subject to satisfaction of customary closing conditions, including receipt of shareholder and regulatory approvals.
DuPont and Dow intend that, following the consummation of the merger, the combined company will pursue the separation of the combined company's Agriculture business, Material Science business and Specialty Products business into three independent, publicly traded companies, subject to the receipt of approval by the DowDuPont board and any required regulatory approvals. The intended subsequent separation into three independent, publicly traded companies is expected to be consummated as soon as practicable following the merger closing, but consummation of the separations is not expected to exceed 18-24 months after the merger closing.


More from AgroNewsChange

Hot Topic More

Subscribe Comment


Subscribe Email: *
Mobile Number:  





Subscribe AgroNews Daily Alert to send news related to your mailbox